Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 75

Tests names and labsConditionsGenes and analytesMethods

CentoColon extended panel

Centogene AG - the Rare Disease Company
Germany
1917
  • C Sequence analysis of the entire coding region

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
4030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Colorectal cancer, hereditary nonpolyposis type 4

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Prostate Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
2015
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Endometrial Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
1712
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Ovarian Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
3521
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

VistaSeq GYN Panel

Molecular Diagnostic Laboratory LabCorp
United States
1111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VisaSeq Breast and GYN Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
3225
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome: MLH1, MSH2, MSH6, PMS2, and EPCAM Sequencing and Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
55
  • C Sequence analysis of the entire coding region

Colorectal Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
2717
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pancreatic Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
2415
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
4131
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Renal Cancer Sequencing Panel

PreventionGenetics
United States
2619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Lynch Syndrome Sequencing Panel with CNV Detection

PreventionGenetics
United States
85
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Lynch Syndrome via PMS2 Gene Sequencing with CNV Detection

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

COLORECTAL CANCER, NONPOLYPOSIC (LYNCH SYNDROME)

Laboratorio de Genetica Clinica SL
Spain
55
  • D Deletion/duplication analysis
  • M Methylation analysis
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Hereditary colon cancer (panel NGS of 21 genes)

CGC Genetics
Portugal
2121
  • C Sequence analysis of the entire coding region

Hereditary nonpolyposis colorectal cancer (metilation analysis and deletions/duplications analysis of MLH1, MLH3, MSH2, MSH3, MSH6, PMS2 and MGMT by MS-MLPA)

CGC Genetics
Portugal
66
  • D Deletion/duplication analysis

Results: 1 to 20 of 75

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center